NCT03132168

Brief Summary

In this study, post-operative delirium will be measured in patients undergoing surgery for bladder resection, and associated microRNA biomarkers will be evaluated in patients considered delirious and non-delirious after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2017

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 27, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

January 10, 2018

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
Last Updated

August 27, 2021

Status Verified

August 1, 2021

Enrollment Period

3.1 years

First QC Date

April 5, 2017

Last Update Submit

August 26, 2021

Conditions

Keywords

cystectomyurologysurgery

Outcome Measures

Primary Outcomes (1)

  • Post-operative delirium

    Evaluate the incidence of and risk factors for POD in patients undergoing radical cystectomy utilizing the Memorial Delirium Assessment Scale.

    up to 3 days post-operatively

Secondary Outcomes (1)

  • microRNA expression

    up to 3 days post-operatively

Study Arms (1)

Subjects undergoing radical cystectomy

OTHER

Subjects involved in the study will be evaluated with various non-invasive assessments including the Richmond Agitation-Sedation Scale, pain assessments on a Numeric Rating Scale (NRS-11), and CAM-ICU scale. Blood draws will also take place in order to perform microRNA testing in all subjects participating in the trial. Standardized anesthetic care as described by the approved protocol will be followed for each subject included in this trial.

Behavioral: AssessmentsProcedure: Blood DrawOther: Standardized Anesthetic Care

Interventions

AssessmentsBEHAVIORAL

These cognitive assessments will be utilized during the study to evaluate cognitive levels comparing prior to surgery and post-operatively in order to determine if the subject is delirious. BIS monitoring will be utilized for all subjects.

Also known as: SAGE scale, Memorial Delirium Assessment Scale
Subjects undergoing radical cystectomy
Blood DrawPROCEDURE

Subjects will have blood draws at surgical preadmission visit, Day 1, Day 2, and Day 3 post surgery only; one tube containing approximately one teaspoon (5 mL) of blood will be drawn at each visit.

Subjects undergoing radical cystectomy

Standardized anesthetic care will be provided as described by the protocol for each subject consented for this trial.

Also known as: Anesthetic Regimen
Subjects undergoing radical cystectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female, 18 years of age and older
  • ASA II or III
  • Capable of and willing to consent
  • Participants literate in English language

You may not qualify if:

  • ASA IV or V
  • Patients with severe visual or auditory impairment
  • Inability to read and/or write in English
  • Presence of a clinically diagnosed major psychiatric condition such as bipolar disorder, uncontrolled major depression, schizophrenia
  • Dementia of Alzheimer's type
  • Parkinson's disease
  • Multiple Sclerosis (MS)
  • Vascular dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Emergence Delirium

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Ahmad Shabsigh, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
No masking
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: All consented subjects will be undergoing elective, scheduled surgeries with standardized anesthesia regimen per protocol. Each participant will complete surveys and procedures as outlined per protocol.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 5, 2017

First Posted

April 27, 2017

Study Start

January 10, 2018

Primary Completion

January 31, 2021

Study Completion

January 31, 2021

Last Updated

August 27, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations